The chip maker's chief executive reiterated confidence in the strength of AI-driven semiconductor demand. The biotech's mRNA vaccines were lauded by the first Trump administration but now are caught ...

The losses weighed heavily on indexes last week, and UnitedHealth was blamed for dragging down both the Dow and the S&P healthcare ... and was worth buying. "The impact ($0.80/share) is being ...

According to their calculations, if UnitedHealth Group (UNH ... Diving deeper into the trading implications, the underperformance of UNH and its impact on the Dow Jones could signal a shift in ...

UnitedHealth's 52-week high is over $630 a share — meaning its drawdown has had an impact of roughly 4 percentage points on the Dow, or roughly 3 percentage points YTD. That's the difference ...

UnitedHealth's 52-week high is over $630 a share — meaning its drawdown has had an impact of roughly 4 percentage points on the Dow, or roughly 3 percentage points YTD. That's the difference between ...

Stocks clawed back their earlier losses on Monday as investors shook off a downgrade of the U.S.’ credit rating by Moody’s.

UnitedHealth's 52-week high is over $630 a share -- meaning its drawdown has had an impact of roughly 4 percentage points on the Dow, or roughly 3 percentage points YTD. That's the difference ...

Now they're also hurting one of the top gauges of the U.S. stock market, as UnitedHealth's plunging shares weigh down the Dow. UnitedHealth is one of the 30 companies that makes up the Dow Jones ...

UnitedHealth is one of the 30 companies that makes up the Dow Jones Industrial Average ... Federal funding for public media is under threat and if it goes, the impact to our communities will be ...